Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
18.56
+1.57 (9.24%)
At close: Jun 26, 2026, 4:00 PM EDT
18.06
-0.50 (-2.69%)
After-hours: Jun 26, 2026, 5:26 PM EDT
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $616.73 million as of June 26, 2026.
Market Cap
616.73M
Enterprise Value
429.11M
1-Year Change
n/a
Ranking
Category
Stock Price
$18.56
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $616.73M, an increase of 99.73%. That is a compound annual growth rate of 96.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 616.73M | 165.99% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4D Molecular Therapeutics | 602.22M |
| Monopar Therapeutics | 587.01M |
| Tectonic Therapeutic | 585.51M |
| Achieve Life Sciences | 585.16M |
| Prime Medicine | 574.36M |
| First Tracks Biotherapeutics | 571.19M |
| Gyre Therapeutics | 569.25M |
| MiMedx Group | 567.48M |